Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 1 day agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 16 hours agoJulPo / Getty Images What Is KP.3? KP.3 is part of a newly identified group of variants dubbed...
There’s a new dominant COVID variant — but are the symptoms any different?
The Hill via Yahoo News· 2 days agoOmicron variant. The latest projections from the Centers for Disease Control and Prevention show...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 13 hours agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Here are 7 things Arizonans need to know about the new KP.3 variant of COVID-19
The Arizona Republic· 2 days agoA new variant of COVID-19 called KP.3 is on the rise in the U.S. and has been detected in Arizona....
Household study suggests infants may spread C difficile
Center for Infectious Disease Research and Policy· 2 hours agoA longitudinal household study found shared C difficile strains in 17 of 28 families, with the...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 12 hours agoAnd while the virus continues to evolve, it’s doing so in more predictable ways. There are new ...
Another COVID vaccine? Yes, and here’s why
Denver Post· 3 days agoThe original virus first detected in Wuhan, China, was replaced by the alpha variant, which was replaced by the delta variant, which was replaced by the...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 3 days agoParticipants in the younger group got either the new vaccine or Spikevax and a standard-dose flu...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 4 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...